Cardiologist (M.D Ph.D. FESC FEACVI FHFA) at MST @ziekenhuisMST #CVImaging #HeartFailure and Researcher at University of Twente @UTwente #digital #eHealth #AI

Joined November 2009
31 Photos and videos
Mark Schuuring retweeted
Challenges of aortic valve stenosis #VHD scenarios: how to get the diagnosis right with @EACVIPresident 🗓️Thursday, 16 October 2025, ⏲️ 18:00 to 19:00 CEST #Webinar Organiser: European Association of Cardiovascular Imaging (EACVI) Register now: 👉esc365.escardio.org/event/20…
12
23
2,228
Mark Schuuring retweeted
🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗nature.com/articles/s41591-0…
8
139
344
37,306
Mark Schuuring retweeted
Development of an Innovative Pipeline With Fusion, Digital Planning, and Three‐Dimensional Printing to Improve Mitral Valve Interventional Care - Man - 2025 - Echocardiography - Wiley Online Library onlinelibrary.wiley.com/doi/…
1
2
4
1,238
Great work @ankeetbhatt !
Thrilled to present #LBCT @escardio #HFA2025 on early readmissions in #FINEARTSHF. Favorable trends with ⏬30-day HF/CV hosp w/ early implementation of #fineranone in currently/recently hospitalized HFmrEF/HFpEF. #SimPub now in @JCardFail! 🙏🏽 @mvaduganathan @scottdsolomon & team
1
1
5
436
Mark Schuuring retweeted
📢 Results of our EASY-STOP study now presented #LBCT at #HeartFailure2025! A thread 🧵 1/ 🚀 First study to evaluate home-based #UNa using a POC sensor to guide loop diuretic downtitration in chronic #HeartFailure patients. #Cardiology #FOAMed
1
16
36
3,327
Mark Schuuring retweeted
🚨 Excited to share our work on #AI #DASSi phenotyping of #AS on 2D #EchoFirst: a low-cost surrogate for multimodality imaging in AS trials A fun collaboration between @cards_lab @rohan_khera & @EdinburghUni (Marc Dweck, @neiljcraig et al) 🔗 Preprint 🧵below #ACC25
1
16
51
3,171
Mark Schuuring retweeted
For all the passionate professionals for cardiovascular imaging, this is your opportunity to mingle with, to network with and to learn from a large community with expertise on 4 modalities. Take advantage and join us! escardio.org/Congresses-Even… @iCorGTrias @imagen_sec

Join Us at the #EACVI 2025 Conference in Vienna! 📅 December 11-13, 2025 📍 Vienna, Austria Experience the future of cardiovascular imaging as #EuroEcho #ICNCCT & #EuroCMR come together under one roof at the #EACVI 2025 Conference! 🔹 Cutting-edge research 🔹 Expert-led sessions 🔹 Multimodality imaging insights 🔹 Networking with global leaders Don’t miss this unparalleled opportunity to advance your knowledge and connect with the best in the field! escardio.org/Congresses-Even… @VDelgadoGarcia @s_e_petersen @denisamuraru @NAjmoneMarsan @anatimoteo46040 @LunaGargani @PezelT @carpenter_jp @rmanka_ @Sarah_Moharem
24
63
4,453
Mark Schuuring retweeted
Proud to be part of this huge effort to synthesize the trial data with IV iron in HF with ID nature.com/articles/s41591-0…
1
25
92
5,697
Mark Schuuring retweeted
Using #ArtificialIntelligence to calculate the heart’s biological age through #ECG data predicts increased risk of mortality and #cardiovascular events 👇 #AI #HeartHealth #EHRA2025 #EHRA_ESC
2
47
129
13,556
Mark Schuuring retweeted
New from #ACC25: Dr. Nuccia Morici & colleagues report the results of ALTSHOCK-2, finding that early implantation of IABP does *not* reduce 60-day mortality in #heartfailure-related cardiogenic shock #JACC 🧵 (1/4)
3
54
182
30,482
Mark Schuuring retweeted
Thrilled to share at #EHRA2025 the Choice-ICD study. An APP co-designed by patients @pumpinghearts @HFWarriorNI1 & clinical experts @BelfastTrust & GJNH, funded by @TheBHF. Ready to start UK testing @UlsterUniSoNP @QUBSONM
4
26
1,268
Mark Schuuring retweeted
Would you discharge an eligible patient with HFrEF w/o one or more disease-modifying, life-saving medications? How about if you knew the odds are 7-15 fold against them ever being initiated as an outpatient? How about if you were contributing to 100K preventable ☠️s per year?
2
19
34
3,051
Mark Schuuring retweeted
What is the likelihood that this RCT will meet its primary endpoint? A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial - Journal of Cardiac Failure onlinejcf.com/article/S1071-… @JCardFail @robmentz @texhern @HFSA

6
13
1,316
Mark Schuuring retweeted
✅ When RCT protocol directed, a large proportion of patients with HFrEF are treated with quadruple GDMT ❌ In clinical practice, when left to clinician discretion, it is < 1 in 10 of patients eligible that are actually treated, even in settings with no cost/access barriers
2
27
46
7,914
Mark Schuuring retweeted
HFmrEF/HFpEF can’t wait Rx the 3 🏛️ SGLTi nsMRA GLP-1 RA (if obesity) The optimal strategy is simultaneous or rapid sequence initiation to all eligible patients, without delay @gcfmd @JavedButler1 @DCRINews @JAMACardio jamanetwork.com/journals/jam…
57
145
10,014
Mark Schuuring retweeted
The role of multi-modality imaging for the assessment of left atrium and #LAA: a clinical consensus statement of the @EACVIPresident & @EHRAPresident of @escardio by @EHJCVIEiC @leylaelifsade et al. ☑️shorturl.at/ukSeX @denisamuraru @EHJIMPEiC @JGrapsa @BakhshiHooman
1
25
58
4,243
Mark Schuuring retweeted

1
11
22
2,278
Mark Schuuring retweeted
Patients with suspected heart failure and elevated NT-proBNP in outpatient care had high mortality and morbidity in the weeks after presentation. Read the results of the REVOLUTION HF study just published in #EHJ 👉 bit.ly/3CSmnns @RoccoMontone @ehj_ed #heartfailure
2
45
127
13,169